Targeted cancer gene panel sequencing of the primary tumor specimens identified a few additional mutations, including one patient each with pathogenic germline mutations in APC and ARID1A, while the remaining mutations were variants of unknown significance (Supplementary Table S3). The gene discussed is ARID1A; the disease is cancer.